Inflammation Blockers May Prolong Pain, Study Suggests

New research from Michigan State University indicates that inhibiting inflammation, often treated with anti-inflammatory drugs, may paradoxically increase the duration of pain. In a mouse study, blocking a key immune molecule, TNF-alpha, reduced inflammation but led to prolonged pain, contrary to researchers' expectations.

The study, published in the Journal of Pain Research, was repeated using different methods, including the drug etanercept, yielding consistent results. Lead author Geoffroy Laumet noted that blocking inflammation prevented the body from naturally resolving pain. This echoes a 2022 study using UK Biobank data, which found individuals taking anti-inflammatories for lower-back pain experienced longer pain durations.

Inflammation's natural role is to protect against infection and aid healing by increasing blood flow and clearing damaged tissue. Pain, while uncomfortable, serves as a protective signal. However, an estimated one-third of the UK population suffers from chronic pain, lasting at least three months, which can be resistant to treatment.

While Professor Laumet emphasizes that further investigation is crucial to determine specific drug applications and conditions, experts like Dr. Devjit Srivastava from NHS Highland suggest that avoiding nerve damage during surgery and managing initial post-operative pain effectively are key to preventing chronic pain. The goal remains managing pain to tolerable levels rather than eliminating it entirely.